These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

805 related articles for article (PubMed ID: 26435097)

  • 1. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.
    Nagatomo Y; Tang WH
    J Card Fail; 2015 Dec; 21(12):973-80. PubMed ID: 26435097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Microbiome in Heart Failure.
    Kitai T; Kirsop J; Tang WH
    Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMAO: how gut microbiota contributes to heart failure.
    Zhang Y; Wang Y; Ke B; Du J
    Transl Res; 2021 Feb; 228():109-125. PubMed ID: 32841736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
    Belli M; Barone L; Longo S; Prandi FR; Lecis D; Mollace R; Margonato D; Muscoli S; Sergi D; Federici M; Barillà F
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary metabolism, the gut microbiome, and heart failure.
    Tang WHW; Li DY; Hazen SL
    Nat Rev Cardiol; 2019 Mar; 16(3):137-154. PubMed ID: 30410105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of intestinal microbiota in patients with heart failure: A systematic review.
    Formiga F; Ferreira Teles CI; Chivite D
    Med Clin (Barc); 2019 Nov; 153(10):402-409. PubMed ID: 31416611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
    Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
    Heart Fail Clin; 2020 Jan; 16(1):23-31. PubMed ID: 31735312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?
    Chaikijurajai T; Tang WHW
    Curr Heart Fail Rep; 2021 Apr; 18(2):23-32. PubMed ID: 33559845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
    Liu X; Cao S; Zhang X
    J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy.
    Dannenberg L; Zikeli D; Benkhoff M; Ahlbrecht S; Kelm M; Levkau B; Polzin A
    Pharmacol Ther; 2020 Sep; 213():107584. PubMed ID: 32446759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
    Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
    Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure.
    Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ
    J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the microbiome for human health: from basic science to clinical applications.
    Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
    Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiome, diet, and links to cardiometabolic and chronic disorders.
    Aron-Wisnewsky J; Clément K
    Nat Rev Nephrol; 2016 Mar; 12(3):169-81. PubMed ID: 26616538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review.
    Mamic P; Chaikijurajai T; Tang WHW
    J Mol Cell Cardiol; 2021 Mar; 152():105-117. PubMed ID: 33307092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Dietary Fiber Reduces Trimethylamine Metabolism via Gut Microbiota and Co-Regulates Host AMPK Pathways.
    Li Q; Wu T; Liu R; Zhang M; Wang R
    Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28884952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure.
    Jia Q; Li H; Zhou H; Zhang X; Zhang A; Xie Y; Li Y; Lv S; Zhang J
    Cardiovasc Ther; 2019; 2019():5164298. PubMed ID: 31819762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
    Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
    Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
    Schulberg J; De Cruz P
    Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.